Membio

Kitchener, Canada Founded: 2018 • Age: 8 yrs
Developer of single-use bioreactors for cell and gene therapies

About Membio

Membio is a Healthcare company based in Kitchener (Canada) founded in 2018 by Shane Kilpatrick and Megan Logan. Developer of single-use bioreactors for cell and gene therapies. Membio has raised $280 thousand across 3 funding rounds from investors including IndieBio, Accelerator Centre and Velocity. Its chief executive, as recorded, is Shane Kilpatrick. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors.

Company details

Membio was founded in 2018 and is based in Kitchener, Canada. Operations focus on the biotechnology sector, where single-use bioreactors are developed for applications in cell and gene therapies. A benchtop bioreactor system is provided, featuring a proprietary design that maintains a consistent cellular environment across scales. This approach supports scalable processes in therapeutic development.

  • Headquarters Kitchener, Canada
  • Founders Shane Kilpatrick, Megan Logan
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website membio.ca
  • Social LinkedIn Facebook
Key Metrics
  • Total Equity Funding
    $280K (USD)

    in 3 rounds

  • Latest Funding Round
    $250K (USD), Seed

    Nov 2019

  • Investors
    IndieBio

    & 2 more

Funding Insights of Membio

Membio has successfully raised a total of $280K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $280,000
  • Total Rounds 3
  • Last Round Seed β€” $250,000
  • First Round $25,000

    (Dec 2018)

  • Investors Count 3

All 3 funding rounds of Membio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2019$250,000Seed–IndieBio
–
Feb 2019$30,000Seed–Accelerator Centre
–
Dec 2018$25,000Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Membio

Membio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include IndieBio, Accelerator Centre and Velocity.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Biotech startups are accelerated through IndieBio's focused programs.
indiebio.coSan Francisco, United States
Startups are built and accelerated in a structured studio environment.
acceleratorcentre.comWaterloo, Canada
Velocity is supported as a startup incubator by the University of Waterloo.
velocityincubator.comKitchener, Canada
Premium access

Investor details for Membio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Membio

2 people are tracked at Membio (2 in leadership).

NameRoleGroup
Shane Kilpatrick
Founder & CEOLeadership
Megan Logan
Co-FounderLeadership
Premium access

Complete people profiles for Membio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Membio

3 dated milestones of Membio across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Membio is founded.
  2. Funding First funding round of $25K.
  3. Funding Latest funding round, Seed, of $250K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Membio

Premium access

Complete news archive for Membio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Membio

Membio was founded in 2018.

Membio is headquartered in Kitchener, Canada. It is registered at Kitchener, Ontario, Canada.

Shane Kilpatrick is the CEO of Membio, as recorded in our data. They have also founded this company.

Membio is a funded company, having raised a total of $280K across 3 funding rounds to date. The company's 1st funding round was a Grant of $25K, raised on Dec 2018.

Membio was founded in 2018 and is based in Kitchener, Canada. Operations focus on the biotechnology sector, where single-use bioreactors are developed for applications in cell and gene therapies. A benchtop bioreactor system is provided, featuring a proprietary design that maintains a consistent cellular environment across scales. This approach supports scalable processes in therapeutic development.

Membio has 3 investors. Key investors include IndieBio, Accelerator Centre, and Velocity.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available